MAZZAGLIA, GIAMPIERO
 Distribuzione geografica
Continente #
NA - Nord America 19.986
AS - Asia 16.034
EU - Europa 9.505
SA - Sud America 2.584
AF - Africa 334
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 12
Totale 48.479
Nazione #
US - Stati Uniti d'America 17.939
SG - Singapore 5.753
VN - Vietnam 2.905
HK - Hong Kong 2.821
IT - Italia 2.582
CN - Cina 2.497
BR - Brasile 2.038
RU - Federazione Russa 1.915
CA - Canada 1.849
IE - Irlanda 1.330
SE - Svezia 851
DE - Germania 791
FR - Francia 493
UA - Ucraina 453
GB - Regno Unito 436
BD - Bangladesh 382
IN - India 322
KR - Corea 262
AR - Argentina 237
ID - Indonesia 193
FI - Finlandia 181
IQ - Iraq 139
TR - Turchia 117
MX - Messico 104
ZA - Sudafrica 104
NL - Olanda 99
PK - Pakistan 89
EC - Ecuador 81
SA - Arabia Saudita 81
PH - Filippine 75
JP - Giappone 63
AT - Austria 60
CO - Colombia 54
ES - Italia 51
PL - Polonia 51
UZ - Uzbekistan 49
MA - Marocco 43
VE - Venezuela 43
EG - Egitto 41
MY - Malesia 41
CH - Svizzera 37
CL - Cile 37
PY - Paraguay 36
BE - Belgio 35
KE - Kenya 27
NP - Nepal 27
JO - Giordania 26
TN - Tunisia 25
AU - Australia 23
UY - Uruguay 22
PE - Perù 20
LB - Libano 19
AE - Emirati Arabi Uniti 18
CZ - Repubblica Ceca 18
TH - Thailandia 18
DO - Repubblica Dominicana 17
IL - Israele 17
AL - Albania 16
JM - Giamaica 16
DZ - Algeria 15
ET - Etiopia 15
IR - Iran 15
RO - Romania 15
CR - Costa Rica 14
KZ - Kazakistan 14
OM - Oman 14
DK - Danimarca 13
AZ - Azerbaigian 12
BO - Bolivia 11
LT - Lituania 11
NG - Nigeria 10
PT - Portogallo 10
TW - Taiwan 10
PA - Panama 9
EU - Europa 8
HN - Honduras 8
MU - Mauritius 8
PS - Palestinian Territory 8
BH - Bahrain 7
LY - Libia 7
NI - Nicaragua 7
GR - Grecia 6
GT - Guatemala 6
HU - Ungheria 6
KG - Kirghizistan 6
MD - Moldavia 6
NO - Norvegia 6
TT - Trinidad e Tobago 6
AO - Angola 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
GY - Guiana 5
KW - Kuwait 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BW - Botswana 4
PR - Porto Rico 4
QA - Qatar 4
Totale 48.407
Città #
Hong Kong 2.791
Singapore 2.614
Fairfield 1.717
Toronto 1.710
Ashburn 1.440
Ann Arbor 1.324
Dublin 1.288
Houston 1.227
Woodbridge 887
San Jose 872
Ho Chi Minh City 853
Santa Clara 670
Seattle 663
Wilmington 655
Hanoi 640
Dearborn 639
New York 631
Princeton 573
Cambridge 545
Milan 512
Chandler 493
Frankfurt am Main 479
Chicago 430
The Dalles 388
Jacksonville 368
Lauterbourg 285
Dallas 284
Moscow 282
Beijing 277
Nanjing 244
Seoul 240
Los Angeles 227
Altamura 221
Lawrence 201
Dong Ket 191
Rome 185
São Paulo 170
Hefei 165
Helsinki 127
Buffalo 115
Andover 108
Council Bluffs 100
San Diego 98
Haiphong 93
Boardman 92
Da Nang 88
Jakarta 87
London 76
Rio de Janeiro 74
Shanghai 73
Guangzhou 70
Munich 62
Nuremberg 61
Changsha 59
Baghdad 55
Ha Long 54
Shenyang 54
Nanchang 53
Orem 53
Hebei 52
Tianjin 49
Tokyo 49
Biên Hòa 48
Ninh Bình 48
Curitiba 46
Ottawa 45
Bologna 43
Jinan 42
Jiaxing 41
Can Tho 40
Salt Lake City 40
Johannesburg 39
Hải Dương 38
Quận Bình Thạnh 37
Tashkent 37
Turin 36
Thái Nguyên 34
Florence 33
Jeddah 33
Mexico City 33
Columbus 32
Brasília 31
Brooklyn 31
Verona 31
Lahore 30
Naples 30
Belo Horizonte 29
Falls Church 29
Mumbai 29
Perugia 29
Dhaka 28
Porto Alegre 28
Quito 28
Zhengzhou 28
Chennai 27
Kocaeli 26
Quận Một 26
Warsaw 26
Amman 25
Riyadh 25
Totale 30.464
Nome #
Triage and Evaluation of Potential Safety Signals Identified from Electronic Healthcare Record Databases 704
Intervention studies in drug utilisation research 562
Epidemiology of SLE in Italy: an observational study using a primary care database 552
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project 545
Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings from 2010 to 2019 529
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 475
Trends in cardiovascular diseases burden and vascular risk factors in Italy: The Global Burden of Disease study 1990–2017 380
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 371
Valutazione del controllo della malattia da reflusso gastroesofageo in Medicina Generale attraverso l’utilizzo del questionario “GERD Impact scale” 368
Use of computerised general practice database for epidemiological studies in italy: a comparative study with the official national statistics 364
Occupational exposure in the lombardy region (Italy) to sars-cov-2 infection: Results from the mustang–occupation–covid-19 study 350
Magnitude and time-course of excess mortality during COVID-19 outbreak: population-based empirical evidence from highly impacted provinces in northern Italy 349
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 341
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 281
User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures 279
Discontinuity and failures of therapy with bisphosphonates: Joint assessment of predictors with multi-state models 276
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 269
Cost-Effectiveness and Budget Impact of Emicizumab Prophylaxis in Haemophilia A Patients with Inhibitors 268
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 257
Risk of severe upper gastrointestinal complications among oral bisphosphonate users 252
The role of electronic healthcare record databases in paediatric drug safety surveillance: A retrospective cohort study 248
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 247
Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection 245
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 242
Harmonisation of Outcome Estraction for Hearth Failure across Data Sources in the SAFEGUARD Project 240
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 238
Azithromycin use and covid-19: a real-world observational study. 235
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 235
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 229
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 225
Effectiveness of oral bisphosphonates for primary prevention of osteoporotic fractures: evidence from the AIFA-BEST observational study 224
Using real-world healthcare data for pharmacovigilance signal detection-the experience of the EU-ADR project 221
Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study 221
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 220
Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study 220
Prescribing pattern of antipsychotic drugs during the years 1996–2010: a population-based database study in Europe with a focus on torsadogenic drugs 219
A Multicentric Prospective Incidence Study of Guillain-Barre Syndrome in Italy. the ITANG Study 218
Cardiovascular diseases burden in Italy, 1990–2017: the Global Burden of Disease Study 214
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 213
Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey 210
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection 209
Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases 209
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 208
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 208
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project 207
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs 207
Screening of older community-dwelling people at risk for death and hospitalization: The assistenza socio-sanitaria in italia project 206
Automatic identification of type 2 diabetes, hypertension, ischaemic heart disease, heart failure and their levels of severity from Italian General Practitioners' electronic medical records: A validation study 203
Effects of a computerized decision support system in improving pharmacological management in high-risk cardiovascular patients: A cluster-randomized open-label controlled trial 202
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 202
Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries 201
Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries 201
Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients 201
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 201
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 200
Food deprivation increases brain nitric oxide synthase and depresses brain serotonin levels in rats 200
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 199
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? 199
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 197
Immeasurable time bias nello studio dell'associazione tra utilizzo di bifosfonati orali e rischio di sanguinamento gastrointestinale. 197
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: Data from the Italian AIFA Anti-diabetics Monitoring Registry 197
Mediation by nitric oxide formation in the preoptic area of endotoxin and tumour necrosis factor-induced inhibition of water intake in the rat 196
Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care 196
'Use of antipsychotics in children and adolescents: A picture from the ARITMO population-based European cohort study' 196
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks and public health considerations 196
Workshop: Indicatori di appropriatezza prescrittiva a sostegno delle politiche sanitarie. Relazione: Valutazione dell’impatto di programmi di minimizzazione del rischio: principi pratici e applicabilità degli indicatori di appropriatezza 194
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network 193
Need and disparities in primary care management of patients with diabetes 193
Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study 192
Use of azithromycin and risk of ventricular arrhythmia 192
Risk of Upper Gastrointestinal Bleeding From Different Drug Combinations 190
Suboptimal Gastroprotective Coverage of NSAID Use and the Risk of Upper Gastrointestinal Complications 190
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 188
Harmonisation of the Event Identification Process in Eight European Healthcare Databases: the experience from the EU-ADR Project. 185
Development and Validation of a Score for Adjusting Health Care Costs in General Practice 185
Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics 184
Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study 183
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease 183
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617 400-patient study 182
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 181
A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care 181
Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures 180
Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases 180
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 179
Using electronic health care records for drug safety signal detection: A comparative evaluation of statistical methods 177
Hypertension in dialysis patients 176
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study 175
Drug-induced progressive multifocal leukoencephalopathy in multiple sclerosis: European regulators' perspective 173
Risk management and drug utilization research 172
Pattern of antimicrobial drug prescribing and prescriptive behaviour for acute otitis media among physicians in Sicily 172
Uso degli antidepressivi in Italia: un’analisi nel contesto della Medicina Generale 171
Chair sessione: storia della sanita’ pubblica II 170
Drug-Induced Acute Myocardial Infarction: Identifying 'Prime Suspects' from Electronic Healthcare Records-Based Surveillance System 169
Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: A focus on elderly with dementia 169
Drug utilization research and risk management 169
Electronic healthcare databases for active drug safety surveillance: is there enough leverage? 169
Is suboptimal prescribing a risk factor for poor health outcomes in community-dwelling elders? The ICARe Dicomano study 169
Antibiotic prescribing for dental conditions: A community-based study in southern Italy 168
Cloricromene antagonizes antidipsogenic effects induced by endotoxin, but not by TNF-alpha, in the rat 168
Prescribing habits of general practitioners in choosing an empirical antibiotic regimen for lower respiratory tract infections in adults in Sicily 166
Totale 23.642
Categoria #
all - tutte 180.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 180.156


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021400 0 0 0 0 0 0 0 0 0 0 0 400
2021/20222.188 125 290 273 165 116 176 128 130 111 76 119 479
2022/20233.413 673 917 287 176 165 628 37 130 220 56 74 50
2023/20243.459 64 116 115 118 556 836 659 94 530 82 76 213
2024/20259.562 509 1.508 450 403 820 226 302 246 1.348 1.180 936 1.634
2025/202619.905 2.285 1.925 1.531 1.955 1.594 913 2.445 1.043 1.614 1.500 2.299 801
Totale 49.866